Static Chart AprilBio Co.,Ltd.

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 27/06/2024 BST			5-day change	1st Jan Change
18,290 ^KRW	-1.14%		-6.21%	+8.55%

06-24	Evommune, Inc. Secures Exclusive Rights to Develop and Commercialize a Phase 2-Ready IL-18 Targeted Fusion Protein from AprilBio	CI
2023	AprilBio Co.,Ltd.(KOSDAQ:A397030) added to S&P Global BMI Index	CI

Duration

Period